Active substance
Results for the substance cabozantinib
3 results
About this active substance
Cabozantinib is a medication used for the treatment of certain types of cancer, including advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. It is a tyrosine kinase inhibitor that blocks multiple signaling pathways involved in tumor growth, angiogenesis, and metastasis.
The medication is taken orally, usually once daily, as directed by a doctor. The dosage may be adjusted based on the patient's response and treatment tolerability.
Common side effects include diarrhea, nausea, fatigue, loss of appetite, high blood pressure, and changes in liver function. In rare cases, more severe adverse effects such as gastrointestinal perforations, severe bleeding, or reversible posterior leukoencephalopathy syndrome may occur.
Cabozantinib is not recommended for pregnant or breastfeeding women, as it may affect fetal development. Patients should inform their doctor about all medications they are taking to avoid drug interactions. Additionally, regular monitoring is important to detect and manage potential adverse effects.
The medication is taken orally, usually once daily, as directed by a doctor. The dosage may be adjusted based on the patient's response and treatment tolerability.
Common side effects include diarrhea, nausea, fatigue, loss of appetite, high blood pressure, and changes in liver function. In rare cases, more severe adverse effects such as gastrointestinal perforations, severe bleeding, or reversible posterior leukoencephalopathy syndrome may occur.
Cabozantinib is not recommended for pregnant or breastfeeding women, as it may affect fetal development. Patients should inform their doctor about all medications they are taking to avoid drug interactions. Additionally, regular monitoring is important to detect and manage potential adverse effects.
-
-
CABOMETYX 60mg film-coated tablets IPSEN ORIGINAL MEDICINE
-
CABOMETYX 40mg film-coated tablets IPSEN ORIGINAL MEDICINE